Replies to post #289679 on NorthWest Biotherapeutics Inc (NWBO)

[anders2211]

Actually, as he states, his numbers are conservative. The price will likely be closer to double his estimate, a multiplier of 10 is common for the industry (what’s the multiplier for Novocure/Optune??), and if this is successful (with no side effects) the only issue will be production in order to keep up with demand.

dear lord But Novocure/Optune actually does HAVE revenue 400 million.
as I posted it will take YEARS for NWBO to gain its full potential in revenue after and if DCVAXL is approved. we were discussing a MC direct after L is approved if it will be approved


Novocure has a MC of 6 billion with a revenue of 300 million.
How on earth will L then get to 20 billion catering the same patients? The MC of Novocure in reality, not fantasy world ONLY confirms my last 5 posts. NWBO will not get a higher MC over 6 billion with L alone. And it will take years to get to 6 billion MC for NWBO with L alone